New drug combo shows promise for rare blood cancer before transplant
NCT ID NCT02223208
First seen Jan 04, 2026 · Last updated May 14, 2026 · Updated 23 times
Summary
This study tests adding romidepsin to standard chemotherapy (CHOEP) in young adults (ages 18-65) with newly diagnosed peripheral T-cell lymphoma. The goal is to see if this combination is safe and effective before a stem cell transplant. About 89 participants will receive the treatment, with researchers monitoring side effects and how long the cancer stays away.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL T-CELL LYMPHOMAS (PTCL) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
A.O. di Perugia - Santa Maria della Misericordia
Perugia, 06132, Italy
-
AO Città della Salute e della Scienza - Ematologia 1U
Torino, TO, 10126, Italy
-
AO Città della Salute e della Scienza - SC Ematologia
Torino, TO, 10126, Italy
-
AO Ospedali Riuniti Villa Sofia - Cervello (Presidio Cervello)
Palermo, PA, 90146, Italy
-
AOU "Santa Maria della Misericordia"
Udine, UD, 33100, Italy
-
AOU di Parma
Parma, PR, 43100, Italy
-
Azienda Ospedaliera Ospedale Niguarda Ca' Granda
Milan, MI, 20162, Italy
-
Azienda Ospedaliera S.Croce e Carle
Cuneo, CN, 12100, Italy
-
Fondazione IRCCS "Istituto Nazionale dei Tumori"
Milan, MI, 20133, Italy
-
Fondazione IRCCS - Policlinico San Matteo
Pavia, PV, 27100, Italy
-
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milan, MI, 20122, Italy
-
IRCCS AOU San Martino - Clinica Ematologica
Genova, GE, 16321, Italy
-
IRCCS AOU San Martino - UO Ematologia 1
Genova, GE, 16321, Italy
-
IRCCS Arcispedale "Santa Maria Nuova"
Reggio Emilia, RE, 42123, Italy
-
IRCCS Centro di Riferimento Oncologico (CRO)
Aviano, PN, 33081, Italy
-
Istituto Clinico Humanitas
Rozzano, Milano, 20089, Italy
-
Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale
Naples, 80131, Italy
-
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.) - Sede di Meldola
Meldola, FC, 47014, Italy
-
Ospedale Borgo Roma
Verona, VR, 37134, Italy
-
Ospedale Businco
Cagliari, CA, 09121, Italy
-
Ospedale G. Da Saliceto - AUSL di Piacenza
Piacenza, 29121, Italy
-
Ospedale Maggiore della Carità - SCDU Ematologia
Novara, 28100, Italy
-
Ospedale SS. Antonio e Biagio e Cesare Arrigo
Alessandria, AL, 15121, Italy
-
Ospedale degli Infermi
Rimini, RN, 47900, Italy
-
Policlinico S. Orsola Malpighi
Bologna, BO, 40138, Italy
-
Spedali Civili
Brescia, BS, 26123, Italy
-
UO Ematologia Ospedale S.Maria delle Croci
Ravenna, 48121, Italy
Conditions
Explore the condition pages connected to this study.